Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
R. Servín-Blanco, R. Zamora-Alvarado, G. Gevorkian & K. Manoutcharian. (2016) Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets. Human Vaccines & Immunotherapeutics 12:10, pages 2640-2648.
Read now
Read now
Cesar A Santa-Maria, Sue Jung Park, Sarika Jain & William J Gradishar. (2015) Breast cancer and immunology: biomarker and therapeutic developments. Expert Review of Anticancer Therapy 15:10, pages 1215-1222.
Read now
Read now
Articles from other publishers (4)
Mengyao Jin, Wei Cao, Bo Chen, Maoming Xiong & Guodong Cao. (2022) Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
T. V. Bauer, T. V. Tregubchak, A. Z. Maksyutov, R. A. Maksyutov, I. V. Kolosova & E. V. Gavrilova. (2020) Development of the drug oncolytic immunotherapy based on vaccinia viruses <i>(Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae)</i> against breast cancer. Problems of Virology 65:1, pages 49-56.
Crossref
Crossref
Austin D. Williams, Kyle K. Payne, Avery D. PoseyJr.Jr., Christine Hill, Jose Conejo-Garcia, Carl H. June & Julia Tchou. (2017) Immunotherapy for Breast Cancer: Current and Future Strategies. Current Surgery Reports 5:12.
Crossref
Crossref
Frederik Marmé. (2016) Immunotherapy in Breast Cancer. Oncology Research and Treatment 39:6, pages 335-345.
Crossref
Crossref